V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 230000060 | 230000036 | 1.66 | null | Adjuvant (A) | 2013-02-22 | 2013-02-23 | GEMCITABINE + NAB PACLITAXEL | N | Y | 230017880 | FLUOROURACIL |
| 230000061 | 230001070 | null | 66.5 | Palliative (P) | null | 2018-01-09 | Cisplatin 100 + RT(H&N) 1 day | null | null | 230018186 | OXALIPLATIN + MDG |
| 230000062 | 230000037 | 1.55 | 50 | Palliative (P) | 2017-10-25 | 2017-11-28 | CAPECITABINE + RT | 02 | N | 230018212 | FEC + DOCETAXEL |
| 230000063 | 230000037 | 1.78 | 69.4 | null | 2014-12-06 | 2014-12-13 | Capecitabine 35days + RT | N | null | 230018212 | ARISTOTLE TRIAL |
| 230000064 | 230000037 | 1.73 | 94 | Palliative (P) | 2013-01-20 | 2013-02-09 | CAPECITABINE + OXALIPLATIN | N | N | 230018212 | CAPECITABINE + OXALIPLATIN |
| 230000065 | 230000037 | 1.6 | 64.4 | Adjuvant (A) | 2016-07-05 | 2016-07-11 | CAPECITABINE + OXALIPLATIN | 2 | N | 230018212 | FLUOROURACIL |
| 230000066 | 230000038 | 1.56 | 61 | Adjuvant (A) | 2015-05-18 | 2015-06-01 | Sorafenib | 02 | N | 230018268 | CAPECITABINE |
| 230000067 | 230000038 | 1.73 | 71.5 | Curative (C) | 2017-08-08 | 2017-08-21 | Cetuximab + FOLFIRI cycle 2 onwards | 2 | Y | 230018268 | CAPECITABINE |
| 230000068 | 230000038 | null | 62 | Palliative (P) | 2015-11-17 | 2015-12-09 | GEMCITABINE | null | null | 230018268 | OXALIPLATIN + MDG |
| 230000069 | 230000038 | 1.8 | 97.1 | Palliative (P) | 2017-04-13 | 2017-04-14 | CYCLOPHOSPHAMIDE + FLUDARABINE + RITUXIMAB | N | N | 230018268 | CAPECITABINE + OXALIPLATIN |
| 230000070 | 230000039 | 0 | 77.3 | Curative (C) | 2014-07-12 | 2014-07-13 | Capecitabine + Oxaliplatin 21day | 2 | Y | 230018466 | CAPECITABINE |
| 230000071 | 230000040 | 1.57 | 61.2 | Adjuvant (A) | null | 2013-09-30 | CYCLOPHOSPHAMIDE + THALIDOMIDE | 2 | Y | 230018489 | FLUOROURACIL + MITOMYCIN + RT |
| 230000072 | 230001073 | 1.68 | null | Not known (9) | 2013-05-13 | 2013-05-17 | Capecitabine + Oxaliplatin 21day | N | null | 230018510 | OXALIPLATIN + RALTITREXED |
| 230000073 | 230001451 | 1.79 | 83.1 | Adjuvant (A) | 2016-05-07 | 2016-05-08 | SCOT TRIAL | 02 | N | 230018688 | IRINOTECAN + MDG |
| 230000074 | 230000041 | 1.81 | 97.6 | Palliative (P) | 2015-03-02 | 2015-03-16 | Gemcitabine 1000mg/m2 D1 8 15 | 02 | N | 230018767 | OXALIPLATIN + MDG |
| 230000075 | 230000042 | 1.83 | 108.5 | Curative (C) | 2014-03-12 | 2014-03-29 | Folfirinox | N | N | 230018904 | CAPECITABINE + OXALIPLATIN |
| 230000076 | 230000042 | 1.75 | null | null | 2015-06-29 | 2015-07-24 | CISPLATIN + RT | N | null | 230018904 | BEVACIZUMAB + CAPE + IRINOTECAN |
| 230000077 | 230000042 | 1.68 | 64.25 | Palliative (P) | 2014-05-04 | 2014-05-12 | Oxaliplatin + Modified de Gramont | N | null | 230018904 | CAPECITABINE |
| 230000078 | 230000042 | 1.62 | 64 | Palliative (P) | 2013-03-06 | 2013-03-28 | Capecitabine | N | N | 230018904 | BEVACIZUMAB + CAPE + OXALIPLATIN |
| 230000079 | 230000043 | 1.56 | 94.6 | Palliative (P) | 2017-12-26 | 2017-12-29 | EC | 02 | N | 230019300 | CETUXIMAB + IRINOTECAN + MDG |
| 230000080 | 230000044 | null | 74 | Neo-adjuvant (N) | 2018-01-13 | 2018-01-13 | Capecitabine 35days + RT | 2 | null | 230019371 | CAP + RT |
| 230000081 | 230000045 | 1.64 | 60.1 | Neo-adjuvant (N) | 2016-03-02 | 2016-04-08 | Capecitabine | N | Y | 230019424 | FLUOROURACIL |
| 230000082 | 230000046 | 1.76 | 74.4 | Neo-adjuvant (N) | 2017-01-24 | 2017-01-24 | CAPECITABINE + OXALIPLATIN | N | Y | 230019471 | CAPECITABINE |
| 230000083 | 230000047 | 1.61 | 79 | Curative (C) | 2015-01-16 | 2015-01-22 | CAPECITABINE + OXALIPLATIN | N | Y | 230019474 | CAPECITABINE |
| 230000084 | 230000048 | 1.86 | 105.8 | Neo-adjuvant (N) | 2016-12-18 | 2017-01-07 | Capecitabine 35days + RT | N | N | 230019489 | CAP + RT |
| 230000085 | 230000049 | 1.65 | 55.2 | Adjuvant (A) | null | 2013-07-08 | CAPECITABINE + OXALIPLATIN | N | N | 230019629 | CAPECITABINE + OXALIPLATIN |
| 230000086 | 230000050 | 1.71 | 57.2 | Neo-adjuvant (N) | 2018-01-24 | 2018-01-31 | Fluorouracil + Folinic Acid Weekly | N | N | 230019732 | OXALIPLATIN + MDG |
| 230000087 | 230001075 | 1.69 | 72 | Palliative (P) | 2017-09-29 | 2017-10-01 | Enzalutamide | 02 | N | 230019807 | CAPECITABINE + RT |
| 230000088 | 230000051 | null | 74.2 | Adjuvant (A) | 2014-11-08 | 2014-11-29 | CAP + RT | N | N | 230019969 | FLUOROURACIL + RT |
| 230000089 | 230000051 | 1.6 | 68.4 | Neo-adjuvant (N) | 2014-04-08 | 2014-04-08 | Carboplatin + Liposomal Doxorubicin | 02 | N | 230019969 | CAPECITABINE + OXALIPLATIN |
| 230000090 | 230000052 | 1.78 | 60 | Curative (C) | 2017-08-26 | 2017-08-29 | VANDETANIB | N | null | 230020101 | CAPECITABINE + OXALIPLATIN |
| 230000092 | 230000054 | 1.82 | 98 | Adjuvant (A) | 2017-07-31 | 2017-08-02 | Capecitabine + Oxaliplatin 21day | 02 | N | 230020293 | CAPECITABINE |
| 230000093 | 230000055 | 1.78 | 73 | Palliative (P) | 2016-06-16 | 2016-07-01 | Fluorouracil + Folinic Acid Weekly | N | N | 230020446 | CAPECITABINE + OXALIPLATIN |
| 230000094 | 230001077 | 1.68 | 69.45 | Adjuvant (A) | 2014-11-16 | 2014-11-30 | Fluorouracil+Mitomycin+RT (Anal Ca) | 02 | N | 230020515 | FLUOROURACIL |
| 230000095 | 230000056 | 1.71 | 93 | null | null | 2013-08-15 | Capecitabine | N | N | 230020525 | CAPECITABINE |
| 230000096 | 230000057 | 1.76 | null | Palliative (P) | 2017-09-12 | 2017-09-15 | Capecitabine + Oxaliplatin 21day | N | null | 230020648 | CAPECITABINE + OXALIPLATIN |
| 230000097 | 230000058 | 1.57 | 96 | Adjuvant (A) | 2017-09-28 | 2017-09-28 | Capecitabine + Oxaliplatin 21day | 02 | Y | 230020683 | FLUOROURACIL |
| 230000098 | 230000058 | 1.55 | 71 | Adjuvant (A) | 2014-02-08 | 2014-02-13 | Capecitabine 35days + RT | 02 | N | 230020683 | CAPECITABINE + OXALIPLATIN |
| 230000099 | 230000059 | 1.7 | 76.7 | Palliative (P) | 2018-08-25 | 2018-08-26 | ESPAC-4 TRIAL | 02 | N | 230020787 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 230000100 | 230000060 | 1.7 | 78.6 | Adjuvant (A) | 2014-01-03 | 2014-01-03 | Capecitabine + Oxaliplatin 21day | 02 | N | 230020843 | IRINOTECAN + MDG |
| 230000101 | 230000061 | 1.7 | 124 | Adjuvant (A) | 2013-07-16 | 2013-07-31 | FLUOROURACIL + IRINOTECAN | N | N | 230020870 | CAPECITABINE |
| 230000102 | 230000062 | 1.66 | 82 | Neo-adjuvant (N) | 2013-08-13 | 2013-08-21 | CAPECITABINE + OXALIPLATIN | null | N | 230021081 | CISPLATIN + RT |
| 230000103 | 230000062 | -1 | 50.9 | null | 2016-01-16 | 2016-01-19 | Fluorouracil+Mitomycin+RT (Anal Ca) | N | null | 230021081 | CAPECITABINE + OXALIPLATIN |
| 230000104 | 230001453 | 1.7 | 79.7 | Palliative (P) | 2008-08-24 | 2014-11-16 | AFATINIB | 02 | N | 230021204 | OXALIPLATIN + MDG |
| 230000106 | 230000064 | 1.8 | 113.1 | Adjuvant (A) | null | 2015-08-11 | Capecitabine + Oxaliplatin 21day | N | N | 230021313 | CAPECITABINE |
| 230000107 | 230001080 | 1.67 | 88.8 | Palliative (P) | 2015-07-27 | 2015-08-11 | PACLITAXEL | N | N | 230021348 | OXALIPLATIN + MDG |
| 230000108 | 230000065 | 1.61 | 61.9 | Adjuvant (A) | 2015-08-22 | 2015-08-27 | Capecitabine + Oxaliplatin 14day | 2 | N | 230021354 | CAPECITABINE + IRINOTECAN |
| 230000109 | 230000066 | 1.65 | 77.6 | Palliative (P) | null | 2018-01-21 | EC | N | null | 230021419 | FLUOROURACIL |
| 230000110 | 230000067 | 1.77 | 80.8 | Adjuvant (A) | 2015-05-09 | 2015-05-09 | CAPECITABINE + OXALIPLATIN | 02 | null | 230021479 | IRINOTECAN + MDG |
| 230000111 | 230000067 | 1.55 | 74 | Curative (C) | 2014-08-08 | 2014-08-18 | EC | N | N | 230021479 | CAPECITABINE |